Author + information
- Received September 5, 2018
- Revision received September 5, 2018
- Accepted September 20, 2018
- Published online January 28, 2019.
- Kanwal M. Farooqi, MDa,∗ (, )
- Cathleen Cooper, MSb,
- Anjali Chelliah, MDa,
- Omar Saeed, MDc,
- Paul J. Chai, MDd,
- Sachin R. Jambawalikar, PhDb,
- Hod Lipson, PhDe,
- Emile A. Bacha, MDd,
- Andrew J. Einstein, MD, PhDb,f and
- Ulrich P. Jorde, MDc
- aDepartment of Pediatrics, Division of Cardiology, Columbia University Medical Center, New York, New York
- bDepartment of Radiology, Columbia University Medical Center, and New York-Presbyterian Hospital, New York, New York
- cDepartment of Internal Medicine, Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York
- dDepartment of Surgery, Division of Pediatric Cardiothoracic Surgery, Columbia University Medical Center, New York, New York
- eDepartment of Mechanical Engineering, Columbia University, New York, New York
- fDepartment of Medicine, Division of Cardiology, Columbia University Medical Center, New York, New York
- ↵∗Address for correspondence:
Dr. Kanwal M. Farooqi, Department of Pediatrics, Division of Cardiology, Columbia University Medical Center, 3959 Broadway, CHN-2, New York, New York 10023.
Advanced imaging modalities provide essential anatomic and spatial information in patients with complex heart disease. Two-dimensional imaging can be limited in the extent to which true 3-dimensional (3D) relationships are represented. The application of 3D printing technology has increased the creation of physical models that overcomes the limitations of a 2D screen. Many groups have reported the use of 3D printing for preprocedural planning in patients with different causes of heart failure. This paper reviews the innovative applications of this technique to provide patient-specific models to improve patient care.
Dr. Lipson is a co-founder of and holds equity in 3DBio, Inc. Dr. Bacha is a scientific council member and consultant for Cormatrix. Dr. Einstein has received research grants from Canon Medical Systems and Roche Diagnostics; and is a consultant for GE Healthcare. Dr. Jorde is an uncompensated consultant for Abbott. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received September 5, 2018.
- Revision received September 5, 2018.
- Accepted September 20, 2018.
- 2019 American College of Cardiology Foundation
This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click Login or the Subscribe link (top menu above) to access this article.